Physician profile
Julie R Rogers
NPI 1083002851
$23,200.84
in general payments reported to CMS, 2019-2025
57 companies · $7,284 in 2025
The $7,284 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,195 · 2022: $5,711 · 2023: $4,937 · 2024: $4,075 · 2025: $7,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Gift: $119 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,151.93 |
| Gift | $118.80 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,167.98 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $2,061.66 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Dexcom, INC. | $1,554.56 | 2022-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Cequr Corporation | $1,298.68 | 2022-2025 | Cequr Simplicity |
| Astrazeneca Pharmaceuticals Lp | $1,154.47 | 2021-2025 | Farxiga, Lokelma |
| Amgen INC. | $970.47 | 2021-2025 | Repatha, Evenity, Tepezza |
| Mannkind Corporation | $962.17 | 2022-2025 | Afrezza |
| Beta Bionics, INC. | $853.27 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Corcept Therapeutics | $838.53 | 2021-2025 | Korlym |
| Ascensia Diabetes Care US INC. | $797.83 | 2023-2025 | |
| Sequel Med Tech, LLC | $737.18 | 2025 | Twiist |
| Sanofi-Aventis U.S. LLC | $701.76 | 2021-2025 | |
| Radius Health, INC. | $678.87 | 2022-2025 | Tymlos |
| Novartis Pharmaceuticals Corporation | $608.14 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $604.95 | 2022-2025 | Jardiance, Synjardy, Tradjenta |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuity Medical INC | $585.78 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Insulet Corporation | $561.63 | 2021-2025 | Omnipod |
| Xeris Pharmaceuticals, INC. | $405.02 | 2021-2023 | Gvoke Hypopen |
| Averitas Pharma INC. | $357.36 | 2024-2025 | Qutenza |
| Tandem Diabetes Care, INC. | $353.83 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Kyowa Kirin, INC. | $348.20 | 2024-2025 | Crysvita |
| Abbott Laboratories | $332.46 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Antares Pharma, INC. | $331.69 | 2021-2023 | Nocdurna, Tlando, Xyosted |
| Recordati_rare_diseases_inc. | $329.59 | 2021-2023 | Signifor Lar, Isturisa |
| Abbvie INC. | $315.68 | 2021-2025 | |
| Madrigal Pharmaceuticals | $280.46 | 2025 | Rezdiffra |
| Medtronic, INC. | $172.75 | 2022-2025 | Minimed 780g |
| Eusa Pharma (US) LLC | $171.25 | 2022 | |
| Amneal Pharmaceuticals LLC | $161.65 | 2021-2023 | Unithroid |
| Bayer Healthcare Pharmaceuticals INC. | $158.62 | 2022-2024 | |
| Shield Therapeutics INC | $125.83 | 2023-2025 | Accrufer |
| Ipsen Biopharmaceuticals, INC | $109.64 | 2022-2023 | Sohonos, Somatuline Depot |
| Ascendis Pharma Endocrinology INC | $108.37 | 2023-2025 | Yorvipath |
| Soleno Therapeutics, INC. | $100.79 | 2025 | Vykat Xr |
| Amarin Pharma, INC. | $93.23 | 2021-2022 | |
| Edwards Lifesciences Corporation | $92.23 | 2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $88.58 | 2025 | General - Erectile Dysfunction |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.87 | 2022-2023 | Cycloset |
| Currax Pharmaceuticals LLC | $68.08 | 2022-2023 | Nexletol |
| Zealand Pharma US, INC. | $61.88 | 2021 | |
| Merck Sharp & Dohme LLC | $61.27 | 2021-2022 | |
| Halozyme INC | $54.33 | 2023 | |
| Alexion Pharmaceuticals, INC. | $40.42 | 2022-2025 | Strensiq |
| Esperion Therapeutics, INC. | $32.65 | 2021 | |
| Neurocrine Biosciences, INC. | $31.64 | 2025 | |
| Acerus Pharmaceuticals Corporation | $26.22 | 2022 | |
| Rgh Enterprises LLC | $24.00 | 2025 | |
| Pfizer INC. | $20.67 | 2025 | |
| Acella Pharmaceuticals, LLC | $18.71 | 2025 | NP Thyroid 60 |
| Astellas Pharma US INC | $16.08 | 2024 | Veozah |
| Becton, Dickinson and Company | $15.37 | 2022 | |
| Vivus LLC | $14.87 | 2021 | |
| Itamar Medical INC | $14.64 | 2022 | |
| Ibsa Pharma INC. | $13.95 | 2023 | Tirosint, Licart |
| Nestle Healthcare Nutrition INC. | $13.42 | 2023 | |
| Clarus Therapeutics INC. | $12.93 | 2021 | |
| Vistapharm, INC. | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.